Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
KenChowder's Profile
Displaying 251-300 of 1190 result(s).
CYDY CytoDyn Inc
11/01/2024 9:32:08 AM
Great, Plot. Hope you can find the (1)
CYDY CytoDyn Inc
11/01/2024 7:45:45 AM
Okay, forgive me. I tried to fill (9)
CYDY CytoDyn Inc
11/01/2024 6:38:47 AM
I'm reposting this. I think it got (14)
CYDY CytoDyn Inc
10/31/2024 4:28:54 PM
RECOVER is the NIH Long-Covid initi (8)
CYDY CytoDyn Inc
10/29/2024 1:24:12 PM
Pretty interesting point or questi (21)
CYDY CytoDyn Inc
10/23/2024 11:07:32 AM
For what it's worth, Dr. Max Latai (23)
CYDY CytoDyn Inc
10/20/2024 11:45:48 AM
Was citing Spike Lee -- at 1:18 her (4)
CYDY CytoDyn Inc
10/20/2024 10:50:47 AM
Groundbreaking clinical trial achie (12)
CYDY CytoDyn Inc
10/19/2024 5:03:25 PM
Kat, for what it's worth, I thought (7)
CYDY CytoDyn Inc
10/19/2024 12:16:09 PM
SAE -- Leronlimab (0/28). Placebo ( (14)
CYDY CytoDyn Inc
10/13/2024 10:25:24 AM
Okay. So if I understand you right, (5)
CYDY CytoDyn Inc
10/13/2024 9:35:04 AM
hey My, help us out a bit more. Yo (12)
CYDY CytoDyn Inc
10/13/2024 9:29:44 AM
No, good results in a clinical tri (9)
CYDY CytoDyn Inc
10/09/2024 7:20:14 AM
I don't think companies are prohib (25)
CYDY CytoDyn Inc
10/09/2024 3:14:25 AM
Here's a readable article about Lat (16)
CYDY CytoDyn Inc
10/08/2024 11:48:52 AM
Euro, this is a 44 minute video app (2)
CYDY CytoDyn Inc
10/07/2024 8:02:34 AM
Understand your concerns, Evil, an (14)
CYDY CytoDyn Inc
10/06/2024 10:53:06 AM
Not only were 57 percent of the TAS (18)
CYDY CytoDyn Inc
10/05/2024 6:51:53 AM
Sounds good. If I understand the s (4)
CYDY CytoDyn Inc
10/04/2024 12:52:56 PM
The word I liked best in the annou (24)
CYDY CytoDyn Inc
10/04/2024 10:10:16 AM
I suspect they heard back from the (7)
CYDY CytoDyn Inc
10/04/2024 9:17:34 AM
On Sept. 9th Dr. Jay said the proto (13)
CYDY CytoDyn Inc
10/04/2024 6:04:04 AM
I think MGK's AI presentation is wo (14)
CYDY CytoDyn Inc
10/01/2024 11:33:16 AM
Paper by Dr. Jay, Dr. Yang, Scott H (16)
CYDY CytoDyn Inc
09/30/2024 9:12:06 AM
Pigs get slaughtered too. You can' (15)
CYDY CytoDyn Inc
09/29/2024 8:46:23 AM
Yes, and it's odd. Basically if yo (12)
CYDY CytoDyn Inc
09/28/2024 4:27:20 PM
I had that same request for an apo (8)
CYDY CytoDyn Inc
09/27/2024 2:06:56 AM
One might cite Bausch Health acquir (14)
CYDY CytoDyn Inc
09/26/2024 4:28:55 PM
Hi MJ, I could well be wrong, but I (10)
CYDY CytoDyn Inc
09/26/2024 10:38:14 AM
On May 20th, Dr. Jay said the Eins (11)
CYDY CytoDyn Inc
09/24/2024 5:03:28 PM
I think this is a misreading of po (13)
CYDY CytoDyn Inc
09/24/2024 12:50:54 PM
You are totally right, House. That (19)
CYDY CytoDyn Inc
09/24/2024 10:45:57 AM
Hi Hoops, not sure which three stu (4)
CYDY CytoDyn Inc
09/24/2024 9:17:43 AM
Just wondering here. Like quite a (19)
CYDY CytoDyn Inc
09/24/2024 8:49:50 AM
Great results. No mention of the co (12)
CYDY CytoDyn Inc
09/21/2024 6:54:00 AM
no clue how long it takes to analyz (22)
CYDY CytoDyn Inc
09/18/2024 10:22:43 AM
I realize you might want to displa (11)
CYDY CytoDyn Inc
09/14/2024 5:24:43 PM
The combo Resmetirom Aramchol paten (1)
CYDY CytoDyn Inc
09/14/2024 2:45:27 AM
I like your cliche, USS. The clich (14)
CYDY CytoDyn Inc
09/09/2024 10:47:26 AM
Pestell sold useless Prostagene to (9)
CYDY CytoDyn Inc
09/09/2024 9:49:35 AM
Dr. RIchard Pestell is back on boa (2)
CYDY CytoDyn Inc
09/05/2024 4:37:31 PM
More on the Why aren't there more (40)
CYDY CytoDyn Inc
09/04/2024 4:51:52 PM
Imagine the Phase I trials for stu (15)
CYDY CytoDyn Inc
09/04/2024 10:58:33 AM
So the people buying the million s (20)
CYDY CytoDyn Inc
08/26/2024 2:49:27 PM
How about conjugating LL with a che (4)
CYDY CytoDyn Inc
08/25/2024 5:08:53 PM
It's not that I'd be sorry to hear (7)
CYDY CytoDyn Inc
08/25/2024 4:36:30 PM
Thanks, MGK. But my question was, (3)
CYDY CytoDyn Inc
08/25/2024 9:43:12 AM
Why do you say this? This Clinical (5)
CYDY CytoDyn Inc
08/16/2024 2:38:17 PM
RECOVER agenda. The NIH-sponsored R (19)
CYDY CytoDyn Inc
08/16/2024 12:47:06 PM
Cyber Security in the 10K. So far a (8)
Go to page:
  • << First
  • < Previous
  • 5
  • 6
  • Next >

Recent Articles

  • Shiba Inu Coin Flourishes as HashJ Introduces New Contracts
  • Recent Stock Insights: Key Players in the Market Breakdown
  • Risetcar's Autonomous Taxis Set to Transform Jakarta's Transport
  • Pan-Mass Challenge: Cyclists Unite for Groundbreaking Research
  • Bitcoin Swift Presale Enters New Phase with Innovative AI Rewards
  • Celebrating Financial Health: Global Impact Champions Awards Launch
  • Avast Emerges as the Top Choice for Antivirus Software
  • FAA Implements Changes to Helicopter Routes after Tragedy
  • Navigating High-Beta Stocks: Echoes of the Dot-Com Boom
  • Understanding the Real Dynamics Behind Portfolio Performance
  • Overview of Financière de Tubize’s Half-Year Performance
  • Financière de Tubize Unveils Promising Financial Results for 2025
  • Legal Actions from Shareholders: Insights on Sarepta and Petco
  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Important Class Action Update for Hims & Hers Health Investors
  • Class Action Lawsuit Emerges Against Flywire Corporation
  • Important Update for Sable Offshore Investors: Act Now
  • Class Action Notice for Neogen Investors: Key Details Inside
  • Tempus AI Faces Legal Challenges Following SEC Allegations
  • Replimune Group Faces Class Action: Key Insights for Investors
  • Neogen Corporation Investors Can Join Class Action Efforts
  • Key Actions for Luminar Technologies Investors Amid Class Action
  • Investors Urged to Act: RxSight Class Action Deadline Approaches
  • Sable Offshore Corp. Class Action: Important Actions for Investors
  • Protecting Your Rights Following Securities Claims with TRSG
  • Investors of Fiserv, Inc. Can Join Class Action for Losses
  • Kepler's K2 Humanoid Robot Revolutionizes Industrial Automation
  • Investor Rights Firm Investigates Potential Mergers and Sales
  • Investigating Stockholder Rights: Olo, Fubo, Arcadia, and Norfolk
  • RxSight Inc. Faces Class Action Lawsuit Over Misleading Claims
  • Spitzer Autoworld Elevates Customer Experience with New VIP Program
  • HashJ Launches New BTC Participation Contracts Amid Market Shift
  • Experience Vibrant Music Events at Great Park Live This Season
  • Explore OLIVE YOUNG's K-Beauty Innovations at KCON LA 2025
  • Discovering the Exceptional Growth of Gartner Stock Today
  • Investors of Sable Offshore Corp. Encouraged to File Claims
  • Senate Bill Secures Funding for OSHA and NIOSH - A Win for Safety
  • Arteris, Inc. Boosts Team with New Inducement Stock Awards
  • Investing in Ameriprise Financial: A 5-Year Review
  • Grupo Cox Makes Major Investment with Iberdrola Acquisition
  • First National Bank Alaska Announces Strong Q3 Dividend Strategy
  • Understanding the Long-Term Value of American Express Stock
  • First National Bank Alaska Announces Third Quarter Dividend
  • Project 61 and Offshift Join Forces for Truck Driver Health
  • Keg Royalties Income Fund Secures Approval for Fairfax Deal
  • The Keg Royalties Income Fund Secures Approval for Key Deal
  • Unlocking the Wealth from Shopify: 15 Years of Growth Insights
  • Lara's Rate Hikes: Consumers Left in Uncertainty Amid Secrecy
  • Barrett-Jackson Holdings Responds to Customer Data Breach
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site